1,000,000+ Servings of fibre soldFive critical biomarkers. One continuous measure from 0 to 100. The clearest way to see how your metabolism is actually doing — and whether it's getting better.
Weight. Blood pressure. Cholesterol. Each of these on its own tells a partial story. The MST Score brings them together — so you see the whole picture, not fragments.
BMI measures mass. It can't tell the difference between muscle and fat, doesn't see where that weight is stored, and misses the metabolic markers that actually predict disease risk.
Our score includes waist measurement — a stronger predictor than BMI for metabolic risk.
A cholesterol reading. A glucose result. A blood pressure check. On their own, these are data points. Together, they're a pattern — and the pattern is what matters.
Five biomarkers combined into one continuous score.
You can't improve what you don't measure. Metabolic change happens over weeks and months — not years — and the people who see real progress are the ones who can watch it happen.
Track your score weekly, see the trend, course-correct when it matters — not when it's too late.
The MST Score is Clubwell's easy, convenient and reliable measure for metabolic health. Developed by leading doctors in the field, it encompasses five metabolic markers internationally recognised as the standard for assessing metabolic health.
It works by looking at results from a few simple but important measurements — taken from your body and a finger-prick blood test — to give you one easy-to-understand number between 0 and 100.
Higher score = better metabolic health.
Tape measure around the waist
Blood fats, from a finger-prick test
The "good" cholesterol, finger-prick test
Fasting glucose, finger-prick test
With a home BP monitor
Once your five measurements are entered into the Clubwell app, your MST Score is calculated and returned as a number between 0 and 100.
Treat your score as a range of plus or minus 10. This allows for natural variables — time of day, how relaxed you were during your blood pressure reading, whether you were bloated during your waist measurement.
If your score is 75, your true range is 65 to 85. Taking your measurements under similar conditions each time leads to more consistent and accurate results.
Your MST Score combines multiple important markers into one number. Here's what you can do with it.
Watch your score move week to week — so you can tell what's actually working and what isn't. The trend tells a truer story than any single reading.
Spot early warning signs for conditions like type 2 diabetes and heart disease — before symptoms appear, when there's still time to change course.
Test real changes — diet, sleep, exercise — and watch how they shift your score. You stop guessing which habits actually help, and double down on the ones that do.
Walk into appointments with a clear number and a history of measurements — and leave with a more focused, productive conversation than "I think I've been feeling tired lately."
The thresholds used to calculate your MST Score, for every measurement.
| Measurement | Criteria | Score Impact |
|---|---|---|
| Waist Circumference | Men <90 cm Women <80 cm | Positive |
| Men 90–93.9 cm Women 80–81.9 cm | No impact | |
| Men 94–102 cm Women 82–88 cm | Negative | |
| Men >102 cm Women >88 cm | Increased negative | |
| Waist-to-Height Ratio | <0.5 | Positive |
| Measurement | Criteria | Score Impact |
|---|---|---|
| Fasting Triglycerides | <1.3 mmol/L | Increased positive |
| 1.3–1.69 mmol/L | Positive | |
| 1.7–1.99 mmol/L | No impact | |
| 2.0–2.29 mmol/L | Negative | |
| >2.29 mmol/L | Increased negative | |
| HDL Cholesterol | Men >1.0 mmol/L Women >1.3 mmol/L | Positive |
| Triglyceride:HDL Ratio | <1.3 | Positive |
| Measurement | Criteria | Score Impact |
|---|---|---|
| Fasting Glucose | <5.5 mmol/L | Increased positive |
| 5.5 mmol/L | Positive | |
| 5.6 mmol/L | No impact | |
| 5.7–6.9 mmol/L | Negative | |
| >6.9 mmol/L | Increased negative | |
| Taking T2D medication | Yes | Increased negative |
| Measurement | Criteria | Score Impact |
|---|---|---|
| Blood Pressure | Systolic <120 and Diastolic <80 mmHg | Increased positive |
| Systolic 120–129 and/or Diastolic 80–84 mmHg | Positive | |
| Systolic 130–139 and/or Diastolic 85–89 mmHg | No impact | |
| Systolic 140–159 and/or Diastolic 90–99 mmHg | Negative | |
| Systolic 160–179 and/or Diastolic 100–109 mmHg | Increased negative | |
| On BP medication | Yes | Increased negative |
Your fasting glucose score may be calculated differently using your HbA1c level — a 3-month average of blood sugar — instead of a single fasting glucose reading.
Blood pressure medications will adjust your blood pressure score. Diabetes medications will adjust your glucose score.
The MST Score draws on peer-reviewed research from the Lancet, Circulation, BMJ, and the European Heart Journal. Every threshold and calculation is traceable to the sources below.
Alberti et al. Harmonizing the Metabolic Syndrome. Circulation 120(16):1640–5.
Jayedi A, Soltani S, Zargar MS, Khan TA, Shab-Bidar S. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ 2020;370:m3324.
Indices of central fatness — including waist circumference, waist-to-hip ratio, waist-to-height ratio, waist-to-thigh ratio, body adiposity index, and A body shape index — independent of overall adiposity, were positively and significantly associated with a higher all-cause mortality risk.
Brown KF, Rumgay H, Dunlop C, Ryan M, Quartly F, Cox A, et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015. British Journal of Cancer. 2018;118(8):1130–41.
Population attributable fractions were calculated for combinations of risk factor and cancer type with sufficient / convincing evidence of a causal association. Overweight / obesity has the second highest PAF after smoking because it affects a high proportion of the UK population and is also linked with many cancer types.
Ashwell M, Gibson S. Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference. BMJ Open 2016;6(3):e010159.
da Luz PL, Favarato D, Faria-Neto JR, Jr., Lemos P, Chagas ACP. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. Clinics (Sao Paulo). 2008;63(4):427–32.
Elevation in the ratio of TG to HDL-c was the single most powerful predictor of extensive coronary heart disease among all the lipid variables examined.
Miller et al. Triglycerides and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation 2011;123:2292–2333.
Alberti et al. Harmonizing the Metabolic Syndrome. Circulation 120(16):1640–5.
Alberti et al. Harmonizing the Metabolic Syndrome. Circulation 120(16):1640–5.
Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings from the Look AHEAD Study. Journal of the American Heart Association. 2021;10(7):e016947.
In a large sample of overweight / obese adults with T2DM, we observed that low HDL-C and metabolic dyslipidemia were each associated with higher risks of atherosclerotic CVD events.
Boizel et al. Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels. Diabetes Care 2000 Nov;23(11):1679–1685.
Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings from the Look AHEAD Study. Journal of the American Heart Association. 2021;10(7):e016947.
In a large sample of overweight / obese adults with T2DM, we observed that low HDL-C and metabolic dyslipidemia were each associated with higher risks of atherosclerotic CVD events.
Williams B et al. 2018 ESC / ESH Guidelines for the management of arterial hypertension. European Heart Journal, Volume 39, Issue 33, 01 September 2018, Pages 3021–3104.
Collaborators GBDRF, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(10010):2287–323.
In terms of global attributable deaths, years of life lost, years lived with disability, and disability-adjusted life-years in 2013, six risks or clusters of risks each caused more than 5% — dietary risks accounting for 11.3 million deaths and 241.4 million DALYs, and high systolic blood pressure for 10.4 million deaths and 208.1 million DALYs.
Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings from the Look AHEAD Study. Journal of the American Heart Association. 2021;10(7):e016947.
In a large sample of overweight / obese adults with T2DM, we observed that low HDL-C and metabolic dyslipidemia were each associated with higher risks of atherosclerotic CVD events.
Alberti et al. Harmonizing the Metabolic Syndrome. Circulation 120(16):1640–5.
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.
Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, et al. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women. JAMA Cardiology. 2021.
In this cohort study, diabetes and insulin resistance, in addition to hypertension, obesity, and smoking, appeared to be the strongest risk factors for premature onset of CHD.
Zhang AMY, Wellberg EA, Kopp JL, Johnson JD. Hyperinsulinemia in Obesity, Inflammation, and Cancer. Diabetes Metab J. 2021.
Recent evidence demonstrates that hyperinsulinemia may play a role in inflammation, aging and development of cancers.
American Diabetes Association. Glucose calculator (HbA1c to eAG). professional.diabetes.org/diapro/glucose_calc
